The genitourinary tumour drug developer's latest round follows a June series C-plus round featuring C&D, Tigermed and SAIC Capital.

3M Ventures and NTTVC joined new and existing investors to help the cardiopulmonary virtual care provider boost its overall funding to $92m.

Novartis Venture Fund took part in a series B round closed as Catalym prepares to move its lead cancer immunotherapy asset into the clinic next month.

Tasly took part in a $30.2m round for medical imaging services provider Keya Medical Technology, which has now raised cash three times this year.

Nestlé and Cedars-Sinai Medical Center participated in a round that came four months after the precision IBD therapy developer rebranded from Precision IBD.

Corporate venturing units GV and SR One both reinvested as the hearing loss therapy developer pushed its overall funding past the $190m mark.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

CIC and Parkwalk have returned to back patient-focused genomic analysis developer Congenica, bringing its funding total to $85m.

Crown Bioscience spinoff Apollomics has closed a round led by Ping An Capital that will support clinical testing of its immuno-oncology drug pipeline.

Tencent and Legal & General co-led a series C round for genomic testing software provider Congenica that will fund the expansion of its partnership activities.